• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Epstein-Barr Virus Infections

Epstein-Barr Virus Infections - 22 Studies Found

Completed : EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients
: Epstein-Barr Virus Infections
: 2009-08-20
Active, not recruiting : Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents
:
  • Fatigue Syndrome, Chronic
  • Epstein-Barr Virus Infections
  • : 2015-01-07
Completed : Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)
: Epstein-Barr Virus Infections
: 2003-04-08
: Biological: Intravenous injection of EBV specific CTLS The
Completed : Mental Training for CFS Following EBV Infection in Adolescents
:
  • Fatigue Syndrome, Chronic
  • Epstein-Barr Virus Infection
  • : 2015-07-09
    : Behavioral: Mental training
Completed : Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations
: Epstein-Barr Virus Infections
: 2003-10-07
Completed : Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
: Epstein-Barr Virus Infections
: 2003-04-11
: Biological: EBV specific T cells One injection of 2x10^7 cells/m2 from Day 45 post transplant. If EBV DN
Active, not recruiting : A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
:
  • Nasopharyngeal Cancer
  • Epstein Barr Virus Infections

: 2013-02-25
: Drug: MVA-EBNA1/LMP2 vaccine
Completed : Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus
:
  • Epstein Barr Virus Infection
  • Healthy

: 2000-06-24
Completed : Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).
:
  • Epstein-Barr Virus Infections
  • Lymphoproliferative Disorders : 2003-04-08
    : Biological: Intravenous injection of EBV specific CTLs Each patient will receive injections of 2x10e7 ,
Active, not recruiting : Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
:
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Infections

: 2010-03-26
: Biological: Recombinant Epstein-Barr Virus (EBV) Vaccine
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.